FDA.reportPublic FDA data

lamoTRIgine 10 MG/mL Oral Suspension

RxCUI
2724462
RxNorm name
lamoTRIgine 10 MG/mL Oral Suspension
Display name
lamoTRIgine 10 MG/mL Oral Suspension
Full name
lamoTRIgine 10 MG/mL Oral Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:45

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SUBVENITELAMOTRIGINEOWP Pharmaceuticals, Inc.022b0913-f683-4af8-a862-f81b315909b22026-06-04Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2724462

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
022b0913-f683-4af8-a862-f81b315909b2lamoTRIgine 10 MG/mL Oral Suspension [PSN] · lamotrigine 10 MG/ML Oral Suspension [SCD]22These highlights do not include all the information needed to use SUBVENITE ® safely and effectively. See full prescribing information for SUBVENITE ® . SUBVENITE (lamotrigine) oral suspension Initial U.S. Approval: 199420260116